Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer
Lola R. Nogueira, Ana Maderuelo, Manuel Alva Bianchi, Pablo Tolosa, Laura Lema, Juan Montes, Teresa Zumárraga, Ainhoa Madariaga, Luis Manso, Sofía Aragón Sánchez, Consuelo Sanz, Yolanda Ruano, Eva Ciruelos Gil, Rodrigo Sánchez-Bayona · 2026
Read Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer by Lola R. Nogueira, Ana Maderuelo, Manuel Alva Bianchi, Pablo Tolosa, Laura Lema, Juan Montes, Teresa Zumárraga, Ainhoa Madariaga, Luis Manso, Sofía Aragón Sánchez, Consuelo Sanz, Yolanda Ruano, Eva Ciruelos Gil, Rodrigo Sánchez-Bayona (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13300713.txt.
Description
Lola R. Nogueira and co-authors report real world use of the HER2DX genomic assay in early HER2-positive breast cancer, in a 2026 single-center study from Madrid. The twenty-seven gene test returns three scores covering response to pre-surgery therapy, long-term recurrence risk, and HER2 pathway activity. The team reviewed forty-five tested patients treated between 2023 and 2025 and asked how often the scores actually changed management.
Testing altered care in just over half the patients. The response score shifted the choice between starting with drug therapy or surgery in about eighteen percent of cases. It also supported lighter chemotherapy backbones, with ninety percent of high-score tumors clearing completely at surgery. The risk score helped pick chemotherapy foundations within stage II disease, and the activity score tracked laboratory staining intensity. The authors call the assay informative beyond standard pathology, while asking for larger prospective validation.
Catalog record
| CREATOR | Lola R. Nogueira, Ana Maderuelo, Manuel Alva Bianchi, Pablo Tolosa, Laura Lema, Juan Montes, Teresa Zumárraga, Ainhoa Madariaga, Luis Manso, Sofía Aragón Sánchez, Consuelo Sanz, Yolanda Ruano, Eva Ciruelos Gil, Rodrigo Sánchez-Bayona |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |